{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28078844", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "16"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0393-974X", "JournalIssue": {"Volume": "30", "Issue": "4", "PubDate": {"Year": "2016", "Season": "Oct-Dec"}}, "Title": "Journal of biological regulators and homeostatic agents", "ISOAbbreviation": "J Biol Regul Homeost Agents"}, "ArticleTitle": "A natural formula containing lactoferrin, Equisetum arvensis, soy isoflavones and vitamin D3 modulates bone remodeling and inflammatory markers in young and aged rats.", "Pagination": {"StartPage": "985", "EndPage": "996", "MedlinePgn": "985-996"}, "Abstract": {"AbstractText": ["A pivotal role in osteoporosis development is played by radical oxygen species (ROS), the increased production of which is related to inhibited osteoblastic activity and bone formation. A new field of research could involve medicinal plants with antioxidant and protective effects in osteoporosis. Furthermore, considering the multifactorial metabolic aspects of osteoporosis, the pharmacological association of multiple medicinal plants could improve patient response. The aim of the present study is to evaluate in vitro and in vivo the protective effects of a natural formula containing lactoferrin 12%, Equisetum arvensis ES 54%, soy isoflavones 34% and vitamin D3 0.002%, in PBMC and C2C12 cells and in the bone matrix of young (3-month-old) and aged (12-month-old) female Sprague-Dawley rats, following chronic (21 days) administration. In this context, we assayed the activities of several inflammation and bone homeostasis mediators, such as IL-6, TNF\u03b1, PGE2, osteoprotegerin, RANK, RANKL and NFkB. In vitro studies showed that natural formula (5-1000\u03bcg/ml) was able to significantly inhibit ROS and PGE2 production. In the same concentration range, the natural formula inhibited both TNF\u03b1 and IL-6 gene expression. In the in vivo studies, we administered to young and aged female rats the natural formula at 5mg/rat for 21 days, finding a significant reduction in inflammatory PGE2 and NFkB activity. Nevertheless, we observed a significant increase in osteoprotegerin/RANKL ratio only in aged rats, compared to the respective control group. In conclusion, our findings corroborate the rational use of natural formula in the prevention and management of osteoporotic disease."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Menghini", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Ferrante", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Leporini", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Recinella", "ForeName": "L", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Chiavaroli", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Leone", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy."}], "LastName": "Pintore", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Vacca", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Orlando", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, \u0093G. d\u0092Annunzio\u0094 University, Chieti, Italy."}], "LastName": "Brunetti", "ForeName": "L", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "J Biol Regul Homeost Agents", "NlmUniqueID": "8809253", "ISSNLinking": "0393-974X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Bone Density Conservation Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "1C6V77QF41", "NameOfSubstance": "Cholecalciferol"}, {"RegistryNumber": "EC 3.4.21.-", "NameOfSubstance": "Lactoferrin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["analysis"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Bone Density Conservation Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bone Remodeling"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bone and Bones"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cholecalciferol"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Equisetum"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Inflammation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Isoflavones"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lactoferrin"}, {"QualifierName": ["complications"], "DescriptorName": "Osteoporosis"}, {"QualifierName": [], "DescriptorName": "Polymerase Chain Reaction"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Glycine max"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "1", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "17", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28078844", "6"]}}]}